| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
As seen the research paper and other reliable sources such as Pubmed |
Studies shown that AI can analyze medical images forn example X-rays , CT scans ect.AI tools can be quite effective for eraly detection of some diseases that may have been missed in the human eye.As seen in the medicine news Ai have a beter detection and may provide more accurate and precise results. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
I found the information from the article . Some of the options hereare clearly disadvantage so I elimated them first and the help in scheduling patient visits is irrelevant to the benefit in radiology so acts as a second medical option is the most suitable as an answer. |
AI acts as a second medical opinion due to its accuracy in diagnosis .By acting as a second medical option from doctors this could potentially reduce errors and having a second set of "eyes" to validate findings. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
As seen in this article. |
AI literacy allows us to have a deeper understanding of machine learning and deep learning through algorithms.Knowing technical knowledge.Being adaptive to new AI tools and know how AI works in general. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
As seen in several studies in Pubmed and the research paper. |
The color of AI machines are not relevant to a factor influencing the acceptability of Ai among healthcare professionals cause its not relevant to their usage. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
As seen in the article that Social influcence plays a mojor role in affecting the healthcare professional desicion to use AI. |
Social influcence plays a mojor role in affecting the healthcare professional desicion to use AI. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
In the option "AI system requires more space" is a lesser stronger argument than concerns about repleacing healthcare professional.None of the above is definitely not correct ad. increased workload is not relevant to the question becuase it is AI no the IT departmant usage. |
AI may provide advanced diagnotics and treatment plants and can do multiple tasks at the same time which would be effective. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Promoting AI systems more aggressively |
|
As seen in the article |
As seen in the article not all medcial professionals understand and know the more in depth usage of AI and its underlying benefits it could provide to the healthcare industry so promoting AI systems more aggresively would be beneficial. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
The type of medical insurance available |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
None of the above |
|
As seen in the 4.8 Further work and direction heading of the article. |
The article talks about a more robust study design for future research in this domain isby using a mixed-methods approach rather than
exclusively applying a qualitative or quantitative methodology which was what most studies had been used. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
As seen an article called "How is Parkinson's Disease Treated with Stem Cell?" and the article itself given.Also increasing brain size is definitely not an option. |
Parkinson's disease causes the loss of dopaminergic neurons. These neurons help release and regulate dopamine allowing us to function.The stem cells help repair and regenerate new dopaminergic neurons. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
As seen in Figure 1 of the article rats were used in GLP saftey and non safety study also written in the methodology section of the article. |
Usually rats are also genetically similar to humans and ethical regulatory acceptance worldwide for preclinical testing. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
As seen in the "GLP safety testing in nude rats shows no adverse effects and no biodistribution outside the transplant region" header it shows that the study duration was about 9 months |
The preclinical trial, was performed with a a 39-week toxicity, tumorigenicity, and biodistribution study of STEM-PD batch . |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I |
|
As seen in the summary of the article. |
The first-in-human STEM-PD phase I/IIa clinical trial along with the trial design. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
As seen in the RESULTS heading of "Manufacturing and quality control of STEM-PD" |
"GMP grade cell line" GMP complaint conditions needs to be followed to ensure consistent quality and prevention of any contamination whatsoever.Also meeting regulatory requirements and regulatory agencies such as the FDA. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
As it can be concluded from the header of the article that says "GLP safety testing in nude rats shows no adverse effects and no biodistribution outside the transplant region" |
GLP safety testing in nude rats shows no adverse effects and no biodistribution outside the transplant region shows that there were no extreme effects to rats. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells increased cognitive impairments. |
|
As seen in the article |
Key finding was that the Transplanted Cells Increased Cognitive Impairments. helped nude rats. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
As seen in this article for purity markers FOXA2 and OTX2. |
So for purity markers FOXA2 and OTX2 Could be seen from the article to access the purity of STEM -PD batch. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They enhance pluripotency. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Increase in anxiety-like behaviors |
|
Reduction of brain size is definetly eliminated at first glance because its irrelevant. |
-Abnormalities of motor function were found in the rats in the article. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|